Purinol Syrup (Inosiplex)

Adult dose

Adults: The daily dose is 3~4 g of inosine pranobex (60~80 mL of this medicine), administered orally in divided doses of 500 mg~1g (10~20 mL) every 4~6 hours.

Child dose

Children: Administer orally in 6 divided doses per day, at a total daily dose of 50~100 mg/kg of body weight.

This medicine should not be used by individuals who have had allergic reactions to this medicine or its components. Individuals with gout or high blood uric acid levels should use this medicine with caution, as their symptoms may worsen. Those with urinary stones or kidney stones should also use this medicine carefully, as it may increase uric acid levels and worsen symptoms. Individuals with poor kidney function should be cautious, as this medicine may take longer to be eliminated from the body. Patients taking the heart medication digoxin should be careful, as this medicine can affect the heart. Taking this medicine may cause gastrointestinal problems, such as discomfort, diarrhea, constipation, nausea, vomiting, and stomach pain. Blood tests may show an increase in red blood cell count, a decrease in white blood cells, and an increase in platelet count. Liver function tests may show elevated levels, and allergic reactions such as skin rashes may occasionally occur. There may be an increase in blood uric acid levels, so monitoring is necessary. Kidney-related issues may lead to an increase in blood urea nitrogen levels and may cause kidney stones, increased urine output, and sometimes urinary stones. Neurological symptoms such as headaches, dizziness, fatigue, irritability, drowsiness, and insomnia may occur. Joint pain may arise, and rarely, interstitial pneumonia may develop, causing inflammation in the lungs. This medicine can elevate uric acid levels in the blood and urine, so it's advisable to have regular checks of uric acid levels and kidney function during treatment. Although this medicine does not have serious drug interaction warnings, it is advisable not to use it in conjunction with cortisone, globulin, immunosuppressants, or antithymocyte globulin. Women who are pregnant or potentially pregnant should carefully consider the risks and benefits of using this medicine, and it is especially recommended not to use it during the first three months of pregnancy. This medicine can also be passed through breast milk, so it is advisable to discontinue nursing during treatment. In cases of overdose, symptoms such as vomiting, headaches, discomfort, dizziness, and palpitations may occur, but these symptoms will disappear by reducing the dosage or stopping the medication. Treatment may be necessary to alleviate symptoms in cases of overdose.

Upper abdominal discomfort, diarrhea, constipation, gastrointestinal bleeding, nausea, vomiting, stomach pain, increased red blood cells, decreased white blood cells, increased platelets, elevation of AST/ALT, elevation of γ-GTP, elevation of ALP, elevation of LDH, rash, hyperuricemia, increased BUN, kidney stones accompanied by hypercalcemia, polyuria, urinary stones, headache, dizziness, fatigue, malaise, nervousness, drowsiness, insomnia, joint pain, interstitial pneumonia, palpitations

This medicine should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy and safety for a long time.

Appearance

Colorless to pale brown syrup with caramel flavor

Package unit

500 milliliters/bottle